FDA clears at-home subcutaneous induction for Skyrizi in Crohn’s disease
Federal prosecutors charge 15 in a Los Angeles health care fraud takedown, the FDA approves bepirovirsen (Hibsago) for chronic hepatitis B, and Skyrizi gains at-home subcutaneous induction for Crohn’s disease.
Justice Department charges 15 in $2 billion Los Angeles health care fraud takedown
The Justice Department charges 15 in a $2 billion Los Angeles health care fraud takedown, a personalized mRNA melanoma vaccine cuts recurrence risk by 42%, and the FDA approves bepirovirsen for hepatitis B.
10/21/26 Daily D
Nigeria has become the fifth country to detect the Bundibugyo virus in the current outbreak, WHO says. An immunotherapy alone may let some patients avoid chemotherapy, radiation and surgery. GSK's bepirovirsen lets some patients on long-term antivirals try stopping treatment. Prosecutors proved Patrick Britton-Harr billed for respiratory tests nobody ordered during the COVID-19 pandemic.
The Daily Digest
An immunotherapy-only regimen may let some patients with a rare rectal cancer subtype skip chemotherapy, radiation and surgery. Kenya has confirmed local spread of the Bundibugyo strain of Ebola, for which no approved vaccine or specific treatment exists. A warehouse cooler problem prompted a Class I recall of hot dogs, bacon, sausage and deli meats sold nationwide. Health care companies that find possible criminal fraud now have one place to report it.
Weekly Debrief October
Pope Leo XIV’s cancer surgery. The 71-year-old pope was diagnosed with the most common form of lung cancer and released from the hospital days after surgery. On Sunday he thanked crowds in St. Peter’s Square and said he’ll gradually return to his usual duties.
Russia tells WHO no plague cases in Irkutsk as lab worker’s death goes unexplained
Russia tells WHO there are no plague cases in Irkutsk, New York declares a measles disaster emergency, and the FDA approves the first heart valve designed to grow with children.